Fatty liver in thin people — lean MASLD — is more common than most patients realise, especially in South Asians. Dr. Chetan Kalal explains causes, diagnosis, and treatment.
Lean Fatty Liver: Why Thin People Get MASLD and What To Do About It Read More »
ACLF is a medical emergency with 28-day mortality of 30-90% depending on organ failure grade. India’s leading ACLF hepatologist explains diagnosis, AARC criteria, treatment, and how international families can get a specialist second opinion within 48 hours.
India’s top liver transplant centres match Western survival rates at 20-30% of the cost. A hepatologist at Gleneagles Hospital Mumbai breaks down costs, LDLT vs DDLT, success rates, and the step-by-step process for NRI and international patients.
SBP is a life-threatening infection in cirrhotics with ascites. A hepatologist covers PMN diagnosis criteria, cefotaxime, mandatory albumin (1.5 g/kg day 1), hepatorenal syndrome prevention, and long-term norfloxacin prophylaxis.
Hepatic encephalopathy (HE) ranges from subtle cognitive impairment to coma. A hepatologist explains ammonia, West Haven grades, precipitants, lactulose, rifaximin, nutrition, and when to transplant.
Hepatic Encephalopathy: Symptoms, Grades, and Treatment in Cirrhosis Read More »
Portal hypertension is the pressure complication that drives variceal bleeding, ascites, and encephalopathy in liver disease. A practising hepatologist explains causes, HVPG measurement, Baveno VII criteria, NSBBs, TIPS, and when to consider liver transplantation.
Portal Hypertension: Causes, Diagnosis and Treatment in Liver Disease Read More »
What is Hepatitis B Reactivation? Hepatitis B reactivation (HBVr) is a sudden increase in HBV replication in a patient with chronic or resolved hepatitis B infection, leading to hepatic inflammation and in severe cases, acute liver failure or ACLF. Reactivation can be spontaneous or triggered by immunosuppressive therapy, chemotherapy, or biologics. Dr. Chetan Kalal at Gleneagles Hospital Mumbai specialises in hepatitis B management including reactivation prophylaxis and treatment of severe reactivation with ACLF. Who Is At Risk? HBsAg-positive patients starting chemotherapy, corticosteroids, TNF inhibitors, IL-6 inhibitors, or JAK inhibitors Anti-HBc-positive (HBsAg-negative) patients receiving rituximab or B-cell depleting therapies — high reactivation risk even without active HBV (occult HBV) Organ transplant recipients on long-term immunosuppression HIV-HBV co-infected patients starting antiretroviral therapy Key principle: Screen ALL patients for HBsAg AND anti-HBc before any immunosuppressive therapy. This is mandatory per APASL, EASL, and AASLD guidelines. Symptoms Jaundice, dark urine, pale stools Fatigue, nausea, right upper quadrant discomfort Elevated ALT/AST (often asymptomatic in early reactivation) Severe: ascites, encephalopathy, coagulopathy — signs of ACLF or acute liver failure Prevention: Antiviral Prophylaxis Tenofovir (TAF or TDF) or entecavir started 1–2 weeks before immunosuppression and continued 6–12 months after cessation dramatically reduces reactivation risk. Lamivudine is no longer recommended for prophylaxis due to high resistance rates. Treatment Immediate antiviral therapy (tenofovir or entecavir) is mandatory on confirmed reactivation. Reduce or stop immunosuppression where feasible. Severe reactivation with ACLF or acute liver failure requires ICU care and urgent liver transplant evaluation. FAQs Can I reactivate if HBsAg is negative? Yes — anti-HBc-positive, HBsAg-negative patients (resolved HBV) can reactivate with rituximab or stem cell transplant. Anti-HBc testing is essential before major immunosuppression. Best antiviral for prophylaxis? Tenofovir alafenamide (TAF) or TDF preferred. High barrier to resistance and proven efficacy. Entecavir is an acceptable alternative. Lamivudine not recommended for prolonged prophylaxis. Hepatitis B specialist in Mumbai? Dr. Chetan Kalal at Gleneagles Hospital Mumbai manages complex hepatitis B cases including reactivation. Teleconsultation available for patients in UK, USA, UAE, and internationally. Author: Dr. Chetan Kalal, Hepatologist, Gleneagles Hospital Mumbai. ORCID: 0000-0002-5284-7890. Hepatitis service page.
Hepatitis B Reactivation: Who Is at Risk, How to Prevent It, and Treatment Read More »
NAFLD is Now Called MASLD In 2023, a multi-society consensus (EASL, AASLD, APASL) officially renamed Non-Alcoholic Fatty Liver Disease (NAFLD) to MASLD — Metabolic dysfunction-Associated Steatotic Liver Disease. NASH is now called MASH (Metabolic dysfunction-Associated Steatohepatitis). The biology is identical; the new name removes the stigmatising label, emphasises metabolic syndrome as the driver, and creates a cleaner taxonomy. How Common is MASLD in India? MASLD is the most common liver disease in India, with prevalence estimated at 25–38% of the adult population. Rising obesity, type 2 diabetes, and sedentary lifestyles are driving a parallel epidemic. Importantly, lean MASLD — fatty liver in non-obese individuals — is especially prevalent in the Indian subcontinent. When Does Fatty Liver Become Dangerous? Simple steatosis (F0–F1): Usually benign; reversible with lifestyle change MASH with early fibrosis (F1–F2): Elevated risk; close monitoring and lifestyle intervention MASH with advanced fibrosis (F3–F4/cirrhosis): High risk of liver failure, portal hypertension, and hepatocellular carcinoma. Annual FibroScan recommended. Can Fatty Liver Be Reversed? Lifestyle modification (first-line): 7–10% body weight reduction resolves MASH in most patients. Mediterranean diet, avoid sugar-sweetened beverages, 150–300 minutes of moderate exercise per week, complete alcohol abstinence. Pharmacological (2024–2025): Semaglutide (GLP-1 agonist): Significant evidence for weight loss and MASH resolution Resmetirom: FDA-approved March 2024 — first approved drug for MASH with fibrosis (F2–F3) Pioglitazone: Useful in type 2 diabetes with MASH FAQs Does fatty liver cause pain? Most MASLD patients have no symptoms. Some have mild right upper quadrant discomfort or fatigue. Significant pain warrants hepatologist evaluation. Can I drink alcohol with fatty liver? No. Alcohol worsens MASLD at any stage and increases fibrosis risk. Complete abstinence is recommended by all current guidelines. How is MASLD diagnosed? Liver ultrasound is the initial test. FibroScan quantifies fat (CAP score) and fibrosis (liver stiffness). Biopsy remains gold standard for definitive staging when non-invasive tests are inconclusive. Author: Dr. Chetan Kalal, Hepatologist, Gleneagles Hospital Mumbai. MASLD service page. ORCID: 0000-0002-5284-7890.
Why NRI Patients Choose India for Liver Transplant India has become one of the world’s top destinations for liver transplantation — combining internationally trained hepatologists, high-volume centres, and costs that are a fraction of those in the UK, USA, UAE, Canada, or Australia. For NRI patients, Mumbai offers direct international flights, familiar language, family support, and world-class care at centres like Gleneagles Hospital. Dr. Chetan Kalal, the first DM Hepatologist of Maharashtra and liver transplant physician at Gleneagles Hospital Mumbai, coordinates transplant care for patients from the UK, USA, UAE, Gulf (GCC), Canada, Australia, New Zealand, and Africa. Cost Comparison: India vs UK, USA, UAE Country Approximate Cost USA USD 300,000 – 500,000+ UK (private) GBP 150,000 – 250,000 UAE USD 150,000 – 250,000 Canada CAD 200,000 – 350,000 Australia AUD 200,000 – 350,000 India (Mumbai) USD 25,000 – 40,000 Costs vary by centre, donor type, and complexity. Approximate ranges for comparison only. Living Donor vs Deceased Donor LDLT (Living Donor Liver Transplant) is the most common and practical route for international patients. A compatible family member donates approximately 60% of their liver. Both livers regenerate within 6–8 weeks. LDLT avoids the deceased-donor waitlist entirely. How to Arrange a Liver Transplant from Abroad Initial teleconsultation — Send LFT, INR, CBC, creatinine, viral markers, MRI abdomen. Dr. Kalal reviews and advises on transplant indication. Donor evaluation — Blood group, liver volumetry, fitness assessment. Partial workup possible in home country. Travel to Mumbai — Evaluation completed in 5–7 days before listing. Surgery and recovery — ICU 5–7 days; hospital stay 2–3 weeks; return home 4–6 weeks post-transplant. Follow-up — Immunosuppression managed with local physician; teleconsultation with Dr. Kalal. FAQs Can patients from Dubai get a liver transplant in Mumbai? Yes. Mumbai is a 3-hour direct flight from Dubai. Dr. Kalal provides initial teleconsultation before travel. Many Gulf patients choose Mumbai for transplantation. Is the quality comparable to UK or USA? Top Indian centres achieve 1-year survival of 85–90%, comparable to leading Western centres. Surgeons are internationally trained with fellowships from USA, UK, and Germany. What visa is needed? Indian Medical Visa (MED) for the patient and attendant. Gleneagles Hospital provides the required sponsorship letter. Author: Dr. Chetan Kalal, Gleneagles Hospital Mumbai. For international consultation: contact Dr. Kalal. ORCID: 0000-0002-5284-7890.
What is ACLF? Acute-on-Chronic Liver Failure (ACLF) is one of the most severe syndromes in hepatology. The APASL defines it as acute hepatic insult superimposed on chronic liver disease, presenting with jaundice (bilirubin ≥5 mg/dL) and coagulopathy (INR ≥1.5), complicated by ascites and/or encephalopathy within 4 weeks. Dr. Chetan Kalal is a leading ACLF specialist at Gleneagles Hospital Mumbai and has contributed to APASL AARC consensus research. AARC Grading Grade 1 (AARC score 5–7): 28-day mortality approximately 15–20% with optimal medical therapy.Grade 2 (score 8–10): Intermediate mortality; intensive care mandatory.Grade 3 (score 11–15): Mortality exceeds 70% without liver transplantation. Common Precipitants in India Hepatitis B reactivation Alcohol-related liver disease flare Bacterial infections (SBP, pneumonia) Superimposed drug-induced or herbal liver injury Hepatitis E superinfection Treatment Grade 1: Treat the precipitant, nutritional support, lactulose and rifaximin for encephalopathy, prophylactic antibiotics, careful fluid management. Grade 2–3: Immediate tertiary referral. Evaluate for liver transplantation within 7–10 days. Living donor liver transplant (LDLT) is the preferred route in India. FAQs Can ACLF survive without transplant? Grade 1 ACLF can recover with medical management. Grade 2–3 carries high mortality without transplantation. Early AARC scoring and 72-hour reassessment is essential. Best ACLF specialist in Mumbai? Dr. Chetan Kalal at Gleneagles Hospital Mumbai specialises in ACLF management and liver transplant evaluation. Referrals accepted nationally and internationally. Author: Dr. Chetan Kalal, first DM Hepatologist of Maharashtra. ORCID 0000-0002-5284-7890. See also: ACLF service page.
